INTRODUCTION
============

Despite recent advancements in medical treatments, ulcerative colitis (UC) continues to have a relapsing--remitting clinical course, without significant predictors, and colectomy rate of about 30% 10 years after diagnosis \[[@b1-ac-2019-03-29]\]. Prolonged disease increases the risk of progression to colorectal cancer, with cumulative probabilities of 2% by 10 years, 8% by 20 years, and 18% by 30 years \[[@b2-ac-2019-03-29]\]. Restorative proctocolectomy (RPC) using ileal pouch-anal anastomosis (IPAA) was first introduced in 1978, and it is considered as standard treatment for refractory UC \[[@b3-ac-2019-03-29]\]. RPC has enhanced the quality of life among patients with UC by preventing the need for permanent ileostomy and maintaining intestinal continuity.

Previous studies had reported that the overall complication rates of open RPC were up to 30%--40% \[[@b4-ac-2019-03-29]\]. Recent studies showed acceptable outcomes of laparoscopic RPC compared to open RPC with less than 30% \[[@b5-ac-2019-03-29], [@b6-ac-2019-03-29]\]. In Asia, there is a dearth of data on laparoscopic RPC for UC because of the low incidence of UC on the continent \[[@b6-ac-2019-03-29]\]. The incidence and prevalence of UC in Korea have been steadily increasing since the 1980s but are still low compared to Western countries \[[@b7-ac-2019-03-29]\]. However, as dietary habits of Asian countries gradually become westernized, the incidence of inflammatory bowel disease is continually increasing, and there is also a growing need to study and suggest a suitable treatment for UC patients in Asian society. Asan Medical Center manages the colorectal surgery patients in Korea, including those with inflammatory bowel disease, and laparoscopic surgery for UC has been gradually instituted since late the 2000s. With our accumulated experience and data related to laparoscopic RPC, we are now able to compare the short-term outcomes of the laparoscopic vs. open approaches to 2-staged RPC for Korean patients with UC.

METHODS
=======

Patients and data collection
----------------------------

We retrospectively reviewed the data on surgical interventions for UC carried out between January 2009 and December 2016 at Asan Medical Center. From the 109 patients' records initially screened, we excluded 27 patients who underwent 3-stage RPC for severe colitis, 1 patient who underwent 1-stage RPC, and 8 patients who underwent emergency 2-stage RPC. We analyzed the remaining 73 cases, which comprised elective 2-stage RPCs.

We divided the cases into 2 groups---the open and laparoscopic groups---for comparisons of clinical variables and outcomes among UC patients. Recorded demographic and clinical variables were age at diagnosis, gender, body mass index (BMI), duration between diagnosis and surgery, American Society of Anesthesiologists (ASA) physical status classification, smoking history, history of previous abdominal surgery, preoperative medical treatments, indication for operation, preoperative hemoglobin level, preoperative albumin level, and preoperative transfusion requirement. Current smokers included patients who were tobacco smokers at the time of surgery and those who had quit within the previous 1 year. Patients who had quit more than 1 year before surgery were considered as ex-smokers, and the third category based on smoking history included patients who never smoked \[[@b5-ac-2019-03-29]\]. Intraoperative details included use of laparoscopy, operative time, anastomotic configuration, requirement for conversion, and estimated blood loss (EBL). Perioperative and postoperative outcomes included morbidity and mortality within 30 postoperative days, requirement for readmission or reoperation, length of hospital stay (days), time to recovery of bowel function, postoperative pain by numeric pain rating scale (NRS), and postoperative transfusion requirement. The Clavien-Dindo classification (CDC) was applied for the assessment of postoperative morbidity \[[@b8-ac-2019-03-29]\].

Definitions
-----------

We defined the medical intractability as a lack of response to at least 7 days of drug therapy or failure to withdraw steroid therapy. Preoperative UC medications were divided into 4 categories: steroids, biologics (infliximab, adalimumab, or certolizumab pegol), immunomodulators (azathioprine or 6-mercaptopurine), and anti-inflammatory agents (5-aminosalicylic acid or budesonide). As a definition for study purposes, steroid or anti-inflammatory use required the administration of a medication belonging to either respective drug category within the month before surgery. Biologic medication use was defined as the administration of at least one anti-tumor necrosis factor agent infusion of within the 3 months before surgery. Immunomodulator use was defined within 2 months before surgery \[[@b9-ac-2019-03-29]\]. Immunosuppressive medications included steroids, biologics, and immunomodulators but not anti-inflammatory agents.

Ileus was defined as the absence of bowel function by postoperative day 5 or the need for nasogastric tube insertion due to abdominal distension, nausea, or vomiting without evidence of mechanical bowel obstruction. The definition of postoperative small bowel obstruction was based on either imaging studies or operative intervention with findings consistent with mechanical small bowel obstruction after postoperative day 5 \[[@b10-ac-2019-03-29]\]. Septic complications included anastomotic leakage, abdominal abscess, and sepsis or septic shock resulting from anastomotic leakage or abdominal abscess formation.

Operation and postoperative management
--------------------------------------

All surgeries were performed by colorectal disease-specialized surgeons of Asan Medical Center with more than 5-year of experience. Surgical decisions and choice of laparoscopy vs. laparotomy were mainly based on the experience and preferences of the operating surgeon. Straight laparoscopic RPC generally consisted of 5 ports, including a periumbilical camera port and working ports for the left and right upper and lower quadrants. After adequate mobilization and vascular ligation of the terminal ileum, colon, and rectum, the distal rectum was transected using endoscopic linear staplers. A wound protector was placed through a 4- to 8-cm incision through the umbilicus or stoma site. After the bowel segment to be intervened upon was exteriorized, an ileal division and construction of a 10- to 15-cm J pouch were performed extracorporeally. When the pouch--anus anastomosis was completed, a diverting ileostomy was constructed on the right or left lower abdominal quadrant. A mucosectomy was generally indicated when a rectal malignancy or dysplasia was identified.

The same perioperative management was administered to both groups. In general, mechanical bowel preparation was used, and nasogastric tubes were not used. Patient-controlled analgesia combined with intravenous ketorolac was the preferred choice for postoperative pain management. Patients who experienced postoperative pain of NRS 4 or more received an additional intravenous opioid bolus (pethidine 25 mg) on request. We compared the mean number of doses of additional opioid administered during the hospital day between the 2 groups. Each patient was given sips of water on postoperative day 1 and encouraged to ambulate frequently. Incentive spirometry and pharmacologic thromboprophylaxis were also used. Liquid diets were offered to patients once stoma function was confirmed. Patients who could tolerate the liquid diet were offered solid food and started on oral analgesics. Discharge criteria included tolerance of meals without nausea or vomiting, established bowel or stoma function, adequate pain control with oral analgesia, and independent ambulation.

Statistical analysis
--------------------

Data were analyzed using IBM SPSS Statistics ver. 21.0 (IBM Co., Armonk, NY, USA). Discrete values, such as gender, operative indications, preoperative medical treatment, and readmission were compared using Pearson chi-square test or Fisher exact test. Student t-test was used to compare continuous values, such as BMI, operative time, duration of disease, and length of postoperative stay. Data are presented as means ± standard deviation. Univariate and multivariate analyses were performed using the logistic regression model for risk factors of postoperative complications. The results were presented as an odds ratio (OR) and the 95% confidence interval (CI). Variables with a P-value ≤ 0.1 in the univariate analysis were included in the multivariate analysis. Additional multivariate analyses were performed with statistical significance designated at P \< 0.05. The Institutional Review Board (IRB) of our institute approved this study (approval number: S2017-0780-0001). The informed consent was waived by IRB.

RESULTS
=======

Preoperative data and operative details
---------------------------------------

Seventy-three eligible patients who underwent 2-stage RPC for UC by 6 staff surgeons were identified. Patient demographic and clinical characteristics are detailed in [Table 1](#t1-ac-2019-03-29){ref-type="table"}. The laparoscopic group consisted of 26 patients (36%), who had a significantly lower mean BMI than the 47 patients in the open RPC group. There was no significant difference between the 2 groups in terms of smoking prevalence, indications for surgery, preoperative medical treatments, preoperative hemoglobin, and albumin levels, nor the rate of preoperative transfusion.

The laparoscopic group had lower mean values of intraoperative blood loss (P = 0.004), time to recovery of bowel function (P = 0.004), and self-reported pain ratings on the first and 7th postoperative days (P = 0.029 and P = 0.027, respectively) compared to open group ([Table 2](#t2-ac-2019-03-29){ref-type="table"}). There were no conversions of laparoscopy to laparotomy, and there was no significant between-group difference in the mean number of additional opioid doses required during admission.

Postoperative complications
---------------------------

[Table 3](#t3-ac-2019-03-29){ref-type="table"} summarizes and compares overall morbidity in the 2 groups. There were no deaths, and the overall rate of complication was 43.8%, with no significant difference in complication rate between the groups. Two patients each had 2 concurrent morbidities. Postoperative ileus was more frequent in the open group (27.7% vs. 7.7%, P = 0.043). Seventy percent of complications (n = 24) were CDC grade I or II, and there was no significant difference in the rates of all CDC grades between the 2 groups. In the multivariate analysis, current smokers (OR, 44.4; P = 0.003) and open approach (OR, 5.4; P = 0.014) were independent risk factors for postoperative complications after RPC ([Table 4](#t4-ac-2019-03-29){ref-type="table"}).

DISCUSSION
==========

We compared the short-term postoperative outcomes of laparoscopic vs. open RPC for UC and demonstrated that the benefits of laparoscopic RPC include reduced pain and faster recovery of bowel function. Additionally, although preoperative mean BMI, hemoglobin, and albumin were lower in the laparoscopic group, laparoscopic RPC was associated with a lower postoperative complication rate than open RPC; that this difference was not statistically significant might have resulted from the small sample size. Several studies have reported similar advantages of laparoscopic RPC, specifically the reduction in both postoperative pain and postoperative analgesia requirements \[[@b11-ac-2019-03-29], [@b12-ac-2019-03-29]\]. Other studies showed that hospital stay duration and time to tolerability of solid food consumption were shorter with the laparoscopic approach \[[@b13-ac-2019-03-29]\]. Other authors demonstrated that laparoscopic RPC provided patients cosmetic advantages and improved quality of life scores \[[@b14-ac-2019-03-29]\].

Early complications after IPAA include pouch bleeding, leakage, and pelvic sepsis \[[@b15-ac-2019-03-29]\]. Pelvic sepsis is a relatively common and serious complication (5%--10% of cases) of IPAA, and it has been identified as a risk factor for long-term pouch failure \[[@b5-ac-2019-03-29], [@b15-ac-2019-03-29]\]. Wound infection, small bowel obstruction, and postoperative ileus have also been identified as common complications, occurring in 8%--18% of cases \[[@b5-ac-2019-03-29], [@b13-ac-2019-03-29]\]. UC patients who are deemed appropriate candidates for RPC are often undernourished and immunocompromised. These patients frequently have a bleeding tendency, and their bowels are often found to be edematous and friable \[[@b6-ac-2019-03-29]\]. This unfavorable preoperative status might explain the high rates (up to 35%) of early complications after IPAA \[[@b16-ac-2019-03-29]\].

Several mechanisms of postoperative ileus have been proposed in previous studies \[[@b17-ac-2019-03-29]\]. Bowel manipulation can lead to traumatic injury, bowel adhesions, and slower blood flow to the mesentery and bowel wall \[[@b18-ac-2019-03-29], [@b19-ac-2019-03-29]\]. Previous studies demonstrated that intraperitoneal procedures in laparoscopic surgery are performed with relatively minimal manipulation compared to open surgery \[[@b18-ac-2019-03-29], [@b20-ac-2019-03-29]\]; the lower incidence of postoperative ileus in the laparoscopic group of this study may reflect this. Another possible cause for the more frequent ileus in the open group may be the higher postoperative pain intensity reported after the open approach, which may increase postoperative opioid use \[[@b17-ac-2019-03-29]\]. However, when we examined the use of opioids in our data, there were no differences in the type and dose of administration of opioids between the 2 groups, and we could not find any association between opioid use and ileus.

Generally, pelvic complications after RPC can be induced by pelvic sepsis, which can be caused by anastomotic dehiscence and by infected pelvic hematomas \[[@b5-ac-2019-03-29]\]. Allogenic blood transfusion may trigger deleterious immunomodulatory effects that increase the risk of bacterial infection \[[@b21-ac-2019-03-29]\]. According to previous studies, the laparoscopic approach is associated with a significantly lower rate of intraoperative blood loss and less blood transfusion \[[@b5-ac-2019-03-29], [@b22-ac-2019-03-29]\]. In our study, postoperative transfusion was required more frequently in the open group than in the laparoscopic group, but this difference was not statistically significant.

In this study, smoking was one of the independent risk factors for postoperative complications. Previous studies have demonstrated that patients who smoked preoperatively had a higher risk of experiencing general morbidity, including wound complications, general infections, and pulmonary complication after an operation \[[@b23-ac-2019-03-29], [@b24-ac-2019-03-29]\]. Several mechanisms have been suggested to explain the effects of smoking on postoperative morbidity \[[@b25-ac-2019-03-29]\]. Tissue hypoxia, which causes peripheral ischemia, results from the adrenergic effects of nicotine and peripheral vasoconstriction. Degradation of immune function may increase the risk of postoperative infection. Mature collagen fibers are less abundant in smokers, and this can impair the postoperative wound healing process.

Previous studies showed that there was no distinct relationship between anastomosis method and complications and, moreover, other authors proved that stapled anastomosis is better than hand-sewn anastomosis method for IPAA \[[@b26-ac-2019-03-29], [@b27-ac-2019-03-29]\]. In this study, however, hand-sewn anastomosis method was a marginally meaningful factor of fewer complications ([Table 4](#t4-ac-2019-03-29){ref-type="table"}). In our data, hand-sewn anastomosis was performed to only 10 patients and 9 of them underwent RPC for malignancy or dysplasia in rectum or colon. Colonic inflammation of patients who underwent RPC for malignancy or dysplasia is typically better than that of the patient who underwent RPC for medical intractability in their acute phase of the disease, because the neoplastic process occurs after a long duration of disease of more than 10 years despite excellent control of inflammatory symptoms \[[@b28-ac-2019-03-29]\]. In this reason, it might not be sufficient to conclude that the hand-sewn anastomosis was related with fewer complications in our study.

Longer operative time has been cited as a major limitation of laparoscopic RPC \[[@b11-ac-2019-03-29], [@b13-ac-2019-03-29]\]. It has been shown that longer operative time could increase postoperative morbidity \[[@b17-ac-2019-03-29]\]. However, in our study, the mean operative time for the laparoscopic group was not significantly different from that of the open group. As the uptake of laparoscopic surgery for colorectal cancer and inflammatory bowel disease continues to increase, surgeons will become more proficient at laparoscopic RPC, improving operative times and minimizing complications.

The present study had several limitations that were inherent to its retrospective design and the small volume of cases. First, although there is no significant difference in demographic characteristics between the 2 groups, it is possible that the heterogeneity of them still exist. In the open group, 5 patients who had undergone abdominal surgeries before RPC were included, but in the laparoscopic group, no patient had a history of abdominal surgery before RPC. These patients in the open group might affect the rate of operative and postoperative outcomes such as ileus, EBL or operative time. Additionally, lower BMI of laparoscopic group might be the result of the selection bias which came from the surgeons' preference to each approach. Second, we included only elective 2-stage RPCs in the open and laparoscopic groups and excluded all emergent cases, such as toxic megacolon, bowel ischemia, bleeding or perforation, and fulminant colitis to minimize the differences between the 2 groups. Thus, our results are not generalizable and do not reflect the outcomes of all types of RPC cases. Third, a precise definition of "medical intractability" was lacking, and there was uncertainty when distinguishing several medically intractable cases from severe or fulminant colitis. Finally, the overall morbidity rate was higher in the open group, but the between-group difference was not statistically significant; the lack of statistical significance might have resulted from the small number of patients, as previously mentioned.

In conclusion, laparoscopic RPC for UC might be an acceptable approach in selective cases in terms of less pain and faster recovery of bowel function.

No potential conflict of interest relevant to this article was reported.

###### 

Demographics and preoperative data

  Variable                          Total (n = 73)   Open (n = 47)   Laparoscopy (n = 26)   P-value
  --------------------------------- ---------------- --------------- ---------------------- ---------
  Age at operation (yr)             43.9 ± 13.5      43.7 ± 13.1     44.1 ± 13.9            0.902
  Male sex                          28 (39)          17 (36)         9 (35)                 0.894
  Body mass index (kg/m^2^)         20.1 ± 3.1       21.1 ± 3.6      19.0 ± 2.4             0.025
  ASA PS classification                                                                     0.294
   I                                9 (12)           4 (9)           5 (19)                 
   II                               57 (78)          38 (81)         19 (73)                
   III                              4 (6)            2 (4)           2 (8)                  
   IV                               3 (4)            3 (6)           0 (0)                  
  Smoking history                                                                           0.318
   Never                            42 (58)          30 (64)         12 (46)                
   Current smoker                   10 (14)          5 (11)          5 (19)                 
   Ex-smoker                        21 (29)          12 (26)         9 (35)                 
  Previous abdominal operation      5 (7)            5 (11)          0 (0)                  0.085
  Duration of disease (mo)          75.7 ± 82.6      84.1 ± 73.8     67.3 ± 93.6            0.402
  Preoperative medical treatments                                                           
   Steroid                          57 (78)          36 (77)         21 (81)                0.680
   Anti-inflammatory agent          57 (78)          35 (75)         22 (84)                0.262
   Immunomodulator                  34 (47)          18 (38)         16 (62)                0.057
   Biologic agent                   20 (27)          12 (26)         8 (31)                 0.631
  Indications for operation                                                                 
   Medical intractability           54 (74)          35 (75)         19 (73)                0.897
   Malignancy or dysplasia          19 (26)          12 (25)         7 (26.9)               0.897
  Preoperative hemoglobin (g/dL)    11.1 ± 1.5       11.3 ± 1.7      10.8 ± 1.2             0.169
  Preoperative albumin (g/dL)       3.0 ± 0.5        3.1 ± 0.5       2.9 ± 0.5              0.074
  Preoperative transfusion          29 (40)          17 (36)         12 (46)                0.404

Values are presented as mean ± standard deviation or number (%).

ASA PS, American Society of Anesthesiologists physical status.

###### 

Intraoperative and postoperative results

  Variable                          Total (n = 73)   Open (n = 47)   Laparoscopy (n = 26)   P-value
  --------------------------------- ---------------- --------------- ---------------------- ---------
  Intraoperative                                                                            
   Operative time (min)             225.6 ± 45.2     221.8 ± 41.3    233.9 ± 54.8           0.288
   EBL (mL)                         275.5 ± 202.1    345.6 ± 376.5   165.5 ± 126.3          0.004
   Anastomosis, hand-sewn           10 (14)          7 (15)          3 (12)                 0.690
  Postoperative                                                                             
   Days to 1st passing of f latus   1.6 ± 0.4        1.7 ± 0.6       1.3 ± 0.5              0.004
   NRS pain score                                                                           
   Postoperative day 1              5.4 ± 2.2        5.8 ± 2.3       4.8 ±2.1               0.029
   Postoperative day 7              2.6 ± 2.1        3.1 ± 2.3       1.8 ± 2.0              0.027
   Hospital stay (day)              11.7 ± 5.0       12.9 ± 7.0      10.0 ± 6.0             0.077
   Reoperation                      3 (4)            2 (4)           1 (3)                  0.933
   Readmission                      13 (18)          9 (19)          4 (15)                 0.687
   Transfusion                      19 (26)          14 (30)         5 (19)                 0.325

Values are presented as mean ± standard deviation or number (%).

EBL, estimated blood loss; NRS, numeric pain rating scale.

###### 

Postoperative complications

  Variable                  Total (n = 73)   Open (n = 47)   Laparoscopy (n = 26)   P-value
  ------------------------- ---------------- --------------- ---------------------- ---------
  Overall complications     32 (44)          24 (51)         8 (31)                 0.094
  Ileus                     15 (21)          13 (28)         2 (8)                  0.043
  Small bowel obstruction   7 (10)           3 (6)           4 (15)                 0.211
  Septic complication       5 (7)            4 (9)           1 (4)                  0.450
  Wound complication        4 (5)            3 (6)           1 (4)                  0.648
  Others                    3 (4)            2 (4)           1 (4)                  0.933

Values are presented as number (%).

The number of patients with ≥2 complications: open 1, laparoscopy 1.

###### 

Univariate and multivariate analyses for postoperative complications

  Variable                         Univariate analysis   Multivariate analysis                       
  -------------------------------- --------------------- ----------------------- ------------------- -------
  Age \> 40 yr                     1.2 (0.5--3.1)        0.731                                       
  Male sex                         1.8 (0.7--4.9)        0.240                                       
  Body mass index \> 25 kg/m^2^    1.4 (0.5--4.1)        0.544                                       
  Smoking history                                                                                    
   Never                           1                     \-                      1                   \-
   Current smoker                  20.1 (2.3--175.3)     0.007                   44.4 (3.8--523.8)   0.003
   Ex-smoker                       2.0 (0.7--6.0)        0.198                                       
  Preoperative steroid use         2.0 (0.6--6.4)        0.256                                       
  Preoperative biologics use       0.6 (0.2--1.8)        0.352                                       
  Preoperative hemoglobin          0.9 (0.7--1.2)        0.715                                       
  Preoperative albumin             1.0 (0.4--2.2)        0.966                                       
  Preoperative transfusion         0.7 (0.3--1.7)        0.410                                       
  Operative approach, open         2.4 (0.9--6.5)        0.098                   5.4 (1.4--20.5)     0.014
  Estimated blood loss \> 300 mL   0.9 (0.3--2.6)        0.801                                       
  Operative time \> 240 min        0.3 (0.1--0.9)        0.021                   0.5 (0.1--2.0)      0.313
  Anastomosis method, hand-sewn    0.1 (0.01--1.0)       0.046                   0.1 (0.01--1.1)     0.056
  Postoperative transfusion        2.9 (1.0--8.6)        0.053                   1.8 (0.5--6.5)      0.397

OR, odds ratio; CI, confidence interval.
